123 related articles for article (PubMed ID: 2272051)
1. Two-phase radioimmunotherapy using bispecific monoclonal antibodies (bs MAbs).
Bosslet K; Hermentin P; Kuhlmann L; Steinstraesser A; Seemann G; Sedlacek HH
Cancer Treat Rev; 1990 Sep; 17(2-3):355-6. PubMed ID: 2272051
[No Abstract] [Full Text] [Related]
2. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
[No Abstract] [Full Text] [Related]
3. Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy.
Bosslet K; Steinstraesser A; Hermentin P; Kuhlmann L; Bruynck A; Magerstaedt M; Seemann G; Schwarz A; Sedlacek HH
Br J Cancer; 1991 May; 63(5):681-6. PubMed ID: 2039692
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs.
Stein R; Juweid M; Mattes MJ; Goldenberg DM
Cancer Biother Radiopharm; 1999 Feb; 14(1):37-47. PubMed ID: 10850286
[TBL] [Abstract][Full Text] [Related]
5. Preparation and use of DTPA-coupled antitumor antibodies radiolabeled with yttrium-90.
Hnatowich DJ; Snook D; Rowlinson G; Stewart S; Epenetos AA
Targeted Diagn Ther; 1988; 1():353-74. PubMed ID: 2979062
[No Abstract] [Full Text] [Related]
6. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody.
Kramer EL; DeNardo SJ; Liebes L; Noz ME; Kroger L; Glenn SD; Furmanski P; Ceriani R
Adv Exp Med Biol; 1994; 353():181-92. PubMed ID: 7985537
[No Abstract] [Full Text] [Related]
8. Antibody targeted therapy in cancer: comparison of murine and clinical studies.
Begent RH; Pedley RB
Cancer Treat Rev; 1990 Sep; 17(2-3):373-8. PubMed ID: 2272053
[TBL] [Abstract][Full Text] [Related]
9. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
Wong JY; Shibata S; Williams LE; Kwok CS; Liu A; Chu DZ; Yamauchi DM; Wilczynski S; Ikle DN; Wu AM; Yazaki PJ; Shively JE; Doroshow JH; Raubitschek AA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5842-52. PubMed ID: 14676105
[TBL] [Abstract][Full Text] [Related]
10. Prediction of tumor response to experimental radioimmunotherapy with 90Y in nude mice.
Dillehay LE; Mayer R; Zhang YG; Shao Y; Song SY; Mackensen DG; Williams JR
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):417-27. PubMed ID: 7673029
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen expression of resurgent human colon carcinoma after treatment with therapeutic doses of 90Y-alpha-carcinoembryonic antigen monoclonal antibody.
Esteban JM; Kuhn JA; Felder B; Wong JY; Battifora H; Beatty JD; Wanek PM; Shively JE
Cancer Res; 1991 Jul; 51(14):3802-6. PubMed ID: 2065334
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial.
Vuillez JP; Kraeber-Bodéré F; Moro D; Bardiès M; Douillard JY; Gautherot E; Rouvier E; Barbet J; Garban F; Moreau P; Chatal JF
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3259s-3267s. PubMed ID: 10541373
[TBL] [Abstract][Full Text] [Related]
13. Therapy of peritoneal carcinomatosis of human colon cancer xenografts with yttrium 90-labeled anti-carcinoembryonic antigen antibody ZCE025.
Hyams DM; Esteban JM; Lollo CP; Beatty BG; Beatty JD
Arch Surg; 1987 Nov; 122(11):1333-7. PubMed ID: 3675197
[TBL] [Abstract][Full Text] [Related]
14. Selection of a DTPA chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice.
Sharkey RM; Motta-Hennessy C; Gansow OA; Brechbiel MW; Fand I; Griffiths GL; Jones AL; Goldenberg DM
Int J Cancer; 1990 Jul; 46(1):79-85. PubMed ID: 2114375
[TBL] [Abstract][Full Text] [Related]
15. Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.
Kraeber-Bodéré F; Faibre-Chauvet A; Saï-Maurel C; Gautherot E; Fiche M; Campion L; Le Boterff J; Barbet J; Chatal JF; Thédrez P
J Nucl Med; 1999 Jan; 40(1):198-204. PubMed ID: 9935077
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of a humanised bispecific monoclonal antibody for cancer therapy.
Bruynck A; Seemann G; Bosslet K
Br J Cancer; 1993 Mar; 67(3):436-40. PubMed ID: 8439495
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma.
Kranenborg MH; Boerman OC; Oosterwijk-Wakka JC; de Weijert MC; Corstens FH; Oosterwijk E
Cancer Res; 1995 Dec; 55(23 Suppl):5864s-5867s. PubMed ID: 7493361
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy of human colon cancer in nude mice.
Buras RR; Beatty BG; Williams LE; Wanek PM; Harris JB; Hill LR; Beatty JD
Arch Surg; 1990 May; 125(5):660-4. PubMed ID: 2331226
[TBL] [Abstract][Full Text] [Related]
19. Clinical-scale radiolabeling of a humanized anticarcinoembryonic antigen monoclonal antibody, hMN-14, with residualizing 131I for use in radioimmunotherapy.
Govindan SV; Griffiths GL; Stein R; Andrews P; Sharkey RM; Hansen HJ; Horak ID; Goldenberg DM
J Nucl Med; 2005 Jan; 46(1):153-9. PubMed ID: 15632046
[TBL] [Abstract][Full Text] [Related]
20. Fractionated radioimmunotherapy using low doses of iodine-131 labeled anti-CEA monoclonal antibody after tumor volume reduction.
Tian J; Ding Y; Zhang J; Cao L; Yin D
Chin Med J (Engl); 2000 Jan; 113(1):53-8. PubMed ID: 11775212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
